COO vs CYCN · P/E 36, rev $4.09B vs $8.6M cap
The Cooper Companies, Inc (COO) versus Cyclerion Therapeutics Inc (CYCN) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. CYCN currently screens at market cap $8.6M.
Not investment advice. Open the COO and CYCN stock pages for the full models.
Not investment advice.